Discover which therapies are expected to grab the HER2-low cancers market share @ HER2-low Cancers Market Report The HER2-low ...

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

Herceptin SC is used to treat breast cancer whose tumour has tested positive to HER2. For more information, see Section 1. Why am I using Herceptin SC? in the full CMI. Do not use if you have ever ...

I maintain a Buy rating on Zymeworks Inc. stock due to platform promise and upcoming catalysts. However, click for why I am ...

Many experts are frustrated and troubled by the state of HER2 testing, especially as new opportunities for tests are on the horizon. And as trials testing Herceptin at earlier stages and in ...

One of the key characteristics is that unlike antibody-based HER2 drugs like Herceptin and Roche’s Perjeta (pertuzumab) and Kadcyla (trastuzumab emtansine) it crosses the blood brain barrier ...

The latest Herceptin biosimilar is branded as Kanjinti (trastuzumab-anns) and is approved in all indications of the reference product. These are for the treatment of HER2-overexpressing adjuvant ...

Cancer patients’ journeys are complex and the benefit of a drug goes well beyond survival, even in cases of incurable and/or ...

Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.

Between 5% and 17% of patients with gastric cancers are HER2-positive, according to study background. First-line treatment includes trastuzumab (Herceptin, Genentech) plus chemotherapy.

A suit cannot be maintained under the Civil law, merely based on an apprehension of litigation, without any concrete or ...

Come Friday, it will be two years since Julie Zimmer rang the bell at the Mercy Health Springfield Cancer Center to celebrate ...